World J Nephrol Urol
World Journal of Nephrology and Urology, ISSN 1927-1239 print, 1927-1247 online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Nephrol Urol and Elmer Press Inc
Journal website http://www.wjnu.org

Original Article

Volume 4, Number 1, March 2015, pages 169-172


Does 24-Hour Urine Supersaturation Predict Stone Composition?

Mohamed Omara, Sarah Tarplina, Alla El Deen El Mahdya, Manoj Mongaa, b

aGlickman Urological & Kidney Institute, Cleveland Clinic Foundation, Cleveland, OH, USA
bCorresponding Author: Manoj Monga, Stevan Streem Center for Endourology & Stone Disease, Glickman Urology & Kidney Institute, The Cleveland Clinic, 9500 Euclid Avenue, Q10-1, Cleveland, OH 44195, USA

Manuscript accepted for publication March 26, 2015
Short title: 24-Hour Urine Supersaturation
doi: http://dx.doi.org/10.14740/wjnu206w

Abstract▴Top 

Background: The aim of the study was to evaluate the correlation between 24-hour urine supersaturation (SS) levels and the crystalline stone composition.

Methods: We retrospectively reviewed the results of stone analysis of 386 patients who had completed 24-hour urine stone risk profiles within 2 months of stone analysis. Patients were characterized as calcium oxalate (CAOX), calcium phosphate (CAPH) or uric acid (UA) stone formers based on the predominant component (> 60%) of their stone. Patients with < 50% of one stone composition were characterized as a mixed stone former. Sensitivity, specificity and accuracy of the 24-hour urine SS for predicting the corresponding stone component were calculated.

Results: The distribution of stone compositions was 235 (61%) CAOX, 98 (25%) CAPH, 35 (9%) UA and 18 (5%) mixed stone group. At predominant stone mineral concentration ≥ 60%, the accuracy of 24-hour urine SS for predicting the predominant stone composition was 52.5% for CAOX, 70% for CAPH and 67% for UA group. Even when the predominant stone mineral concentration was ≥ 90%, the accuracy of SS did not improve: COAX (49%, P = 0.6641), CAPH (77%, P = 0.361) and UA (67%, P = 0.9593).

Conclusions: Twenty-four-hour urine SS has a poor accuracy to predict the predominant stone composition. Accuracy is highest for patients with CAPH stones.

Keywords: Supersaturation; 24 h urine; Stone composition

Introduction▴Top 

It has been suggested that a 24-h urine metabolic evaluation provides the backbone for selection of the most appropriate intervention to prevent stone recurrence [1]. The saturation of urinary salts has been cited for more than four decades as a key risk factor for urolithiasis [2, 3].

Supersaturation (SS) is the driving force for crystallization in solutions such as urine [4], defined as the ratio of the concentration of dissolved salt to its solubility [5]. The consequences of increased urinary SS are formation of crystalline particles that is a preface to stone formation, so that the stone composition should reflect the SS averages during the creation and growth of the stone, as such the stone is a type of geological artifact of SS conditions [6]. SSs have also been utilized to monitor response to medical and dietary interventions for stone prevention [7].

In contrast, other theories for stone formation have emerged in the past decade, including the roles of renal tubular damage and cellular dysfunction [8], urinary kidney stone inhibitors and promoters [9], suggesting that SS is not the sole or even predominant risk factor for stone formation [10].

Though a uric acid (UA), cystine or struvite stone composition may direct preventive measures [11], there are cases where the stone composition is unknown (e.g. stones that were removed or passed but were not sent for analysis or patients with stones in the urinary system that have not yet been removed or eliminated) [12].

Our aim was to determine whether 24-hour urine SSs are well correlated with the crystalline component of stones passed by these patients, such that they could serve as a surrogate for stone analysis.

Materials and Methods▴Top 

We retrospectively reviewed 386 patients from 2012 to 2014 who completed 24-hour urine stone risk evaluations within 2 months of stone analysis. No dietary or medical preventive measures were initiated in the interval between stone analysis and 24-hour urine evaluation.

Patients were sorted into four groups: calcium oxalate (CAOX), calcium phosphate (CAPH), UA and mixed stones based on the major element of stone component being ≥ 60%.

Patients with rare stone types such as cystine and medication-associated stones were excluded.

Stone analyses were performed using Fourier transform infrared spectroscopy and the 24-h urinalyses were performed at Litholink Laboratories (Chicago, IL).

Statistical analysis

Using Fisher’s exact test for categorical data and ANOVA for continuous variables, a comparison between different groups in patient characteristics (including age, sex, height and BMI) and a univariate analysis of 24-h urine variables, across stone type groups were performed using Kruskal-Wallis test for continuous variables and Pearson’s Chi-squared test for categorical variables.

Then at different cut-off values of predominant stone component (≥ 60%, ≥ 70%, ≥ 80%, and ≥ 90%), we determined sensitivity, specificity and accuracy of the 24-h urine SS for prediction of the corresponding each stone composition, considering the other stone groups as a control.

Patients with 24-h urine more than 2 months from date of stone analysis were excluded.

Results▴Top 

Of 386 patients in the study, the mean age was 55 ± 15 years, with an average BMI of 29.6 ± 8.2. There were 216 (57%) males and 170 (43%) females. We sorted the patients into four groups CAOX, CAPH, UA and mixed stone group based on that the major element of stone component represents ≥ 60%.

The distribution of patients across the three groups and their characteristics are reported in Table 1. The time period between stone analyses and 24-h urine collection was 25 ± 35 days (range 10 - 60 days).

Table 1.
Click to view
Table 1. Bivariate Comparison of 24-Hour Urine Elements Across Stone Type Groups
 

The results of the univariate analysis of patient characteristics (including age, sex, height and BMI) and 24-h urine SS, to detect statistically significant differences in between the three stone groups, are reported in Table 1, showing only significant difference for CaP and UA SS in relation to other stone groups but not for CAOX SS (Fig. 1).

Figure 1.
Click for large image
Figure 1. Accuracy of supersaturation at different cut-off values of predominant stone composition.

At predominant stone mineral concentration ≥ 60%, the accuracy of 24-h urine SS for predicting the predominant stone composition was 52.5% for CAOX, 70% for CAPH and 67% for UA group. Even when the predominant stone mineral concentration was ≥ 90%, the accuracy of SS did not improve: COAX (49%, P = 0.6641), CAPH (77%, P = 0.361) and UA (67%, P = 0.9593) (Table 2).

Table 2.
Click to view
Table 2. Accuracy of Supersaturation at Different Cut-Off Values of Predominant Stone
 
Discussion▴Top 

Urolithiasis is a recurrent condition that is accompanied by significant morbidity. Knowing the stone composition is considered an important step in the prevention of its recurrence. SS is a computed value that indicates the likelihood of crystallization given the concentration of relevant ions and the urinary pH [6, 13].

Several studies have investigated the ability of 24-h urine SS to predict urinary stone composition, suggesting that there is a general concordance between urine SS and stone composition. Despite this, the debate around the importance of SS is still heated [6, 13, 14]. We investigated the accuracy of 24-h SS in predicting corresponding stone type at different levels of predominant stone composition. Although others have supported the accuracy of SS in the prediction of stone composition, the definition of different stone composition categories used in these studies has been inconsistent. We calculated the SS accuracy to predict the major stone compositions at increasing percentages of the total stone weight: 60%, 70%, 80% or 90%. Accuracy was low, and there was no significant difference in accuracy with increasing levels of the predominant stone composition. Historically, the SS was considered a good predictor for stone type.

In a prospective, controlled study of 585 patients, Parks et al [6] reported a correlation between SS (measured on three separate 24-h urine collections) and stone composition. Further, the study proposed that SS could serve as an index for urinary response to medical therapy. This is in contrast to our findings, which revealed poor accuracy of 24-h urine SS in prediction of predominant stone composition. We cannot comment on the role of 24-h SS in monitoring response to medical therapy, as this was not assessed in our study. Similarly, the utility and specificity of SS in stone management and its implications for pathogenesis of stones was recently questioned by other authors.

In a prospective, controlled study of 538 patients, Lingeman et al elucidated cases of deviation between 24-h urine SS and predominant stone composition, identifying key patterns. In 14% of their study population, a stone was present but high urinary SS of the main stone constituent was not detected on 24-h urine studies. Conversely, in 19% of cases (type 1 divergence), 24-h urine SS was high in the absence of a stone. In comparison to our study, these markers for specificity and sensitivity suggest better utility of urinary SS of CAOX, CAPH, and UA in the prediction of stone composition. Of note, this study utilized different cut-off values than ours (> 80% for CAOX), > 50% for CAPH, and pure UA stones, which may have resulted in discrepancies between their results and ours. In addition, problems with sensitivity in prediction of expected composition (type 2 divergence) occurred more commonly in patients with CAOX stones, an observation similar to our study. It is possible that the predictive role of urinary SS is dependent on timing of testing, as temporal stone-related dietary changes can present a distorted picture of the patients’ propensity for stone formation. Further, this study is limited by inter-laboratory variability [14]; in our study, the stone analysis was done by single laboratory by infrared spectroscopy and the 24-h urine evaluation was performed by a single laboratory (Litholink, Chicago, IL).

Though the average time between stone analysis and 24-h urine evaluation was short, 2 months, it is certainly feasible that patients may have increased their fluid intake during this interval. A study by Borghi et al [15] of 15 stone-forming patients and 12 controls showed that urine dilution as a result of a water load had the capacity to reduce CAOX SS and increase the urine tolerance to an oxalate load. This suggests that the reliability of different SS formulas on 24-h urine profiles is variable, as it depends on the volume and timing of the collection. Also there was a similar effect of CAOX reduction with water intake among both control and stone-forming groups. This considerable overlap indicates that other mechanism may be involved in stone formation, such as a reduced metastable limit or reduced crystallization inhibitory factors. Although this study highlights some important potential diagnostic limitations of 24-h urine studies, unlike our study, it did not directly examine the correlation between CAOX SS and stone type.

In a review of 47 studies comparing urinary SS of stone formers to healthy individuals, Rodgers [16] found that large variability occurred in both groups, such that stone formers could not be distinguished from healthy individuals based on urinary SS. They concluded that it is unfeasible to define a “high” vs. normal SS value; as such, urinary SS has very limited diagnostic value. This is consistent with our findings of low accuracy of urinary SS, even at high cut-off values for predominant stone composition. Further, the authors suggest that the relationship between SS and stone composition may aid only in for the purpose of relative comparisons to track treatment response. While we did not investigate this role, we do currently use SS to monitor response to dietary and pharmacological interventions.

Moreira et al [12] generated a multinomial logistic model to predict stone type from different 24-h urine variables, including urinary pH, volume, calcium, oxalate, citrate, UA, sodium, potassium, magnesium, phosphorus, sulfate, creatinine, SS CAOX, SS CAPH and SS UA concentrations. This model correctly predicted for CAOX, UA and CAPH, with 64%, 68%, and 56% accuracy, respectively. At 64%, the overall accuracy was not significantly improved as compared to other studies that utilized only urinary SS in the prediction of stone type.

Conclusions

In conclusion, 24-h urine SS alone does not accurately predict the stone composition.

Grant Support

None.

Abbreviations

SS: supersaturation; CAOX: calcium oxalate; CAPH: calcium phosphate; UA: uric acid


References▴Top 
  1. Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327(16):1141-1152.
    doi pubmed
  2. Coe FL, Parks JH. New insights into the pathophysiology and treatment of nephrolithiasis: new research venues. J Bone Miner Res. 1997;12(4):522-533.
    doi pubmed
  3. Tiselius HG. Solution chemistry of supersaturation. In: Coe FL, Favus MJ, Pak CYC et al., editors. Kidney Stones: Medical and Surgical Management. Philadelphia: Lippincott-Raven Publishers; 1996. p. 33-64.
  4. Aggarwal KP, Narula S, Kakkar M, Tandon C. Nephrolithiasis: molecular mechanism of renal stone formation and the critical role played by modulators. Biomed Res Int. 2013;2013:292953.
    doi pubmed
  5. Lande MB, Varade W, Erkan E, Niederbracht Y, Schwartz GJ. Role of urinary supersaturation in the evaluation of children with urolithiasis. Pediatr Nephrol. 2005;20(4):491-494.
    doi pubmed
  6. Parks JH, Coward M, Coe FL. Correspondence between stone composition and urine supersaturation in nephrolithiasis. Kidney Int. 1997;51(3):894-900.
    doi pubmed
  7. Pearle MS, Goldfarb DS, Assimos DG, Curhan G, Denu-Ciocca CJ, Matlaga BR, Monga M, et al. Medical management of kidney stones: AUA guideline. J Urol. 2014;192(2):316-324.
    doi pubmed
  8. Khan SR. Renal tubular damage/dysfunction: key to the formation of kidney stones. Urol Res. 2006;34(2):86-91.
    doi pubmed
  9. Fleisch H. Inhibitors and promoters of stone formation. Kidney Int. 1978;13(5):361-371.
    doi pubmed
  10. Rao PN. Debate: the key to stone formation is. Urol Res. 2006;34(2):79-80.
    doi pubmed
  11. Kourambas J, Aslan P, Teh CL, Mathias BJ, Preminger GM. Role of stone analysis in metabolic evaluation and medical treatment of nephrolithiasis. J Endourol. 2001;15(2):181-186.
    doi pubmed
  12. Moreira DM, Friedlander JI, Hartman C, Elsamra SE, Smith AD, Okeke Z. Using 24-hour urinalysis to predict stone type. J Urol. 2013;190(6):2106-2111.
    doi pubmed
  13. Fink HA, Wilt TJ, Eidman KE, Garimella PS, MacDonald R, Rutks IR, Brasure M, et al. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline. Ann Intern Med. 2013;158(7):535-543.
    doi pubmed
  14. Lingeman J, Kahnoski R, Mardis H, Goldfarb DS, Grasso M, Lacy S, Scheinman SJ, et al. Divergence between stone composition and urine supersaturation: clinical and laboratory implications. J Urol. 1999;161(4):1077-1081.
    doi
  15. Borghi L, Guerra A, Meschi T, Briganti A, Schianchi T, Allegri F, Novarini A. Relationship between supersaturation and calcium oxalate crystallization in normals and idiopathic calcium oxalate stone formers. Kidney Int. 1999;55(3):1041-1050.
    doi pubmed
  16. Rodgers AL. Urinary saturation: casual or causal risk factor in urolithiasis? BJU Int. 2014;114(1):104-110.
    doi pubmed


This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


World Journal of Nephrology and Urology is published by Elmer Press Inc.

 

Browse  Journals  

     

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 

 

 

 

World Journal of Nephrology & Urology, quarterly, ISSN 1927-1239 (print), 1927-1247 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.wjnu.org   editorial contact: editor@wjnu.org    elmer.editorial@hotmail.com
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada
© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.